|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2010-9-27
|
|
pubmed:abstractText |
Neuroendocrine carcinoma (NEC) of the breast, a pathologic entity newly defined in the 2003 World Health Organization classification of tumors, is a rare type of tumor that is not well recognized or studied. The purpose of this first case-controlled study is to reveal the clinicopathologic features, therapeutic response, and outcomes of patients with NEC of the breast.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4463-73
|
|
pubmed:meshHeading |
pubmed-meshheading:20572042-Adult,
pubmed-meshheading:20572042-Aged,
pubmed-meshheading:20572042-Aged, 80 and over,
pubmed-meshheading:20572042-Breast Neoplasms,
pubmed-meshheading:20572042-Carcinoma, Neuroendocrine,
pubmed-meshheading:20572042-Case-Control Studies,
pubmed-meshheading:20572042-Female,
pubmed-meshheading:20572042-Humans,
pubmed-meshheading:20572042-Lymphatic Metastasis,
pubmed-meshheading:20572042-Male,
pubmed-meshheading:20572042-Middle Aged,
pubmed-meshheading:20572042-Neoplasms, Hormone-Dependent,
pubmed-meshheading:20572042-Prognosis,
pubmed-meshheading:20572042-Recurrence,
pubmed-meshheading:20572042-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.
|
|
pubmed:affiliation |
Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
